TIDMAMD 
 
The AIM Distribution Trust plc 
Report & Accounts for the year ended 31 March 2009 
 
FINANCIAL HIGHLIGHTS 
 
 
                                                         2009    2008 
                                                        pence   pence 
 
 
Net asset value (per share)                              33.6    50.3 
 
Cumulative distributions paid since launch               55.8    55.8 
 
Total return (net asset value plus cumulative            89.4   106.1 
distributions paid) 
 
Interim distribution paid (per share)                       -     2.0 
 
 
 
 
CHAIRMAN'S STATEMENT 
As an AIM-focused VCT whose funds have to remain invested, your 
Company is unavoidably exposed to the AIM market conditions. The 
deterioration in the economy over the year ended 31 March 2009 has 
been a significant influence on investor confidence, which has been 
exaggerated in the case of smaller companies. These conditions have 
caused a further fall in your Company's NAV over the year. 
 
Net Asset Value 
At 31 March 2009, the Net Asset Value per share ("NAV") stood at 
33.6p. This represents a decrease of 16.7p or 33.2% since the 
previous year end.   Over the same period the FTSE AIM All Share 
index fell by 57.0%. 
 
VCT investments 
The Company made several additions to its portfolio this year, 
investing GBP101,000 into one follow-on investment and re-invested 
GBP100,000 in one company following a corporate reconstruction. 
 
At the year end, the Company held a portfolio consisting of 37 
investments which were valued at GBP3.0 million.  The portfolio 
generated unrealised losses of GBP1.8 million and realised gains of 
GBP97,000 over the year. 
 
Details of the Company's VCT investments, including additions, 
disposals and performance, are set out within the Investment 
Manager's Report and Review of Investments. 
 
Results 
The loss on ordinary activities after taxation was GBP2,220,000 (2008: 
GBP1,654,000), comprising a revenue loss of GBP31,000 and a capital loss 
of GBP2,189,000. 
 
Dividends 
Shareholders will be aware that the Directors were forced to take the 
unwelcome step of having to cancel the dividend the Company had 
intended to pay in March 2009.  Although the Company had sufficient 
funds and reserves for the dividend, the sharp fall in the portfolio 
valuation over a period of months meant that the Company was unable 
to make the dividend payment without causing a technical breach of 
the Companies Act. 
 
In order to pay further dividends the Company is likely to have to 
undergo a restructuring whereby it will reduce its share capital. 
The Board is reviewing the costs of such an exercise, whilst also 
considering other options for the Company which are discussed further 
below. 
 
Listed fixed income and other investments 
The Company holds a non-qualifying portfolio which includes a holding 
in a fixed income bond and holdings in three hedge funds.  The 
portfolio had a value of GBP975,000 at the year end and generated an 
unrealised loss of GBP455,000 during the year and a realised loss of 
GBP1,000. 
 
Shareholder survey December 2008 
The Company undertook a shareholder survey in December 2008 to try to 
establish the level of Shareholders who deferred capital gains when 
they invested in the Company. The responses to the survey have 
provided the Board with a clear indication that a significant number 
of Shareholders still defer capital gains by virtue of the 
shareholding in the Company.  As a result, the Board has concluded 
that any future strategy must not force Shareholders into a position 
where they cease to hold VCT qualifying shares (such as winding up 
the Company) as this will create a capital gain tax problem for a 
significant number of Shareholders. 
 
Share buybacks 
During the year, the Company bought in 445,637 shares for 
cancellation as an average price of 44.6p per share, which was 
generally at a 10% discount to the latest published NAV. 
 
The Board has reviewed the share buyback policy and decided not to 
acquire any further shares for the time being in order to preserve 
liquid funds within the Company, avoid having to sell the Company's 
more attractive holdings and to prevent the Company from becoming 
unacceptably small as a result of buybacks. 
 
The Directors appreciate that this is likely to make it very 
difficult for Shareholders to dispose of their shares or may result 
in Shareholders being offered prices at a substantial discount to the 
NAV. 
 
Future Strategy 
In light of the above conclusions, the Board now believes the way 
forward may include: 
 (i)        seeking to merge the Company with one or more other VCTs; 
(ii)        undertaking a new fundraising to increase the size of the 
fund; and 
(iii)       refocusing the Company's Investment policy, possibly 
lowering the exposure to AIM. 
 
The Board is exploring possible routes by which it might achieve one 
or more of the above and provide Shareholders with the prospects of 
improved performance, steady dividend flow and some type of share 
buyback facility.  When further progress has been made, I will 
provide Shareholders with further details. 
 
Annual General Meeting 
The Annual General Meeting of the Company will be held at 159 New 
Bond Street, London W1Y 9PA at 10:45am on 8 September 2009. 
 
One special resolution is being proposed at the meeting to renew the 
authority to allow the Company to make market purchases of the 
Company's shares, should the Directors decide to resume share 
buybacks. 
 
Outlook 
Throughout April and May 2009, the FTSE AIM All-Share Index showed 
steady growth.  At 30 May 2009, the Company's NAV had risen by 2.2p 
since the 31 March 2009 to 35.8p per share.  While this is welcomed, 
the state of the economy indicates that this is unlikely to be the 
start of a sustained recovery.  Although there are reports of "green 
shoots", the Board remains cautious and does not believe it is 
realistic to expect that the Company will recover the value it has 
lost over the last 18 months in the short or medium term. 
 
The Board believes that the Company needs to be significantly larger, 
or part of a significantly larger entity, to allow it to best support 
growth and to provide Shareholders with a satisfactory, ongoing 
dividend yield, along with some liquidity in the Company's shares. 
The Board considers this is a realistic goal and will be in touch 
with Shareholders as soon as there is firm news to report. 
 
 
 
 
Sir Aubrey Brocklebank 
Chairman 
 
INVESTMENT MANAGER'S REPORT 
We present an overview of the investment management activities for 
the year ended 31 March 2009. 
 
The last twelve months has been a very challenging period for equity 
markets and a particularly torrid time for the smaller companies 
market.  UK smaller companies share prices have been under pressure 
since the autumn of 2007 when credit markets started to tighten in 
response to defaults in the US sub prime market.  A readjustment of 
risk throughout 2008 saw investors taking a more cautious stance 
towards smaller companies.  The worse falls in share prices occurred 
in the second half of the year as the financial crisis intensified 
with the effects of the credit crunch spreading to the wider economy, 
resulting in the UK economy going into recession in the fourth 
quarter.  It is not unusual at this stage of the economic cycle to 
see investors shy away from small companies.  The falls have been 
exacerbated by poor liquidity and compounded by forced sellers as 
smaller company funds such as unit trusts, experienced redemptions, 
necessitating sales of their underlying investments into an already 
weak AIM share market. 
 
For the record the FTSE 100 shares index showed a fall over the year 
of 31.1%, whilst the FTSE Small Cap Index fell 42.4% and the AIM 
Index declined 57.0%. 
 
With falling asset prices and company valuations, we have pursued a 
cautious reinvestment programme with just one new investment and one 
additional investment into an existing holding. 
 
Hoole Hall Spa & Leisure Ltd is a separate company set up to provide 
spa and leisure facilities for Hoole Hall Country Club Ltd, which is 
a country club hotel located on the Chester Ring Road.  In May 2008 
your Company invested GBP22,000 by way of equity and GBP78,000 into a 
4.15% convertible loan note to help fund the construction of the new 
health club and spa. 
 
Hill Station plc is an ice cream manufacturer based in Cwmbran.  Your 
Company made its initial investment of GBP250,000 in 2005.  Further 
funding of GBP300,000 was provided, to help with working capital 
following a short fall in sales owing to a very wet summer in 2007 
and also to assist with the acquisition of the So Real Ice Company, a 
rival ice cream manufacturer.  A sharp increase in raw material costs 
coupled with suppliers imposing lower credit limits saw a need for 
additional working capital.  In January 2008 your Company 
participated in a fund raising and provided GBP80,000, the majority of 
which was via a 10% loan note. Sales improved, helped by deliveries 
to new customers.  In late March 2008 the company's bank unexpectedly 
imposed a cap on their factoring facility well below normal terms at 
the time when the company was looking to build stock for the summer 
season.  Your Company provided a further GBP100,000 via a 15% loan 
stock to assist with working capital. Unfortunately, customer 
confidence was damaged by these funding difficulties which resulted 
in a loss of business and sales falling below budget.  By late summer 
2008 it was clear that the company would not survive the winter 
months without a further injection of cash.  Given the fragile state 
of the business, your Company together with other investors declined 
to support the rescue plan and the company was placed into 
administration in early October 2008. 
 
The top ten holdings now account for 54% of the value of the 
portfolio.  ANS remains the largest holding in the portfolio, showing 
a small increase over the year helped by new software service 
contracts to the public sector. 
 
Connaught continues to be the second largest holding despite selling 
part of the holding (GBP78,000), for a very substantial profit.  The 
company have continued to gain market share in a fragmented but 
buoyant social housing serving industry.  Their presence in the 
compliance market where local authorities are increasingly looking to 
consolidate into fewer service providers has also benefited them. 
 
Cadbury House has traded well and to budget whilst the building works 
and refurbishment at Hoole Hall have gone well with planning 
permission granted for a further 30 bedrooms to bring the total to 
140 bedrooms.  The hotel has now been badged DoubleTree® by Hilton 
which will allow the company to benefit from the brand recognition 
and Hilton's powerful internet reservation system.  The expected 
increase in clientele will benefit Hoole Hall Spa & Leisure. 
 
Atlantic Global shows an appreciation over the year helped by share 
buy backs, cash on the balance sheet and the release of new cost 
effective, easy to use business management software solutions.  Spice 
moved from the AIM market to the Official List (main market).  Two 
partial sales were undertaken, realising a profit with proceeds of 
GBP71,000.  Since the date of these sales the share price has fallen 
back sharply following the company's announcement of a more 
challenging environment for their facilities business and a change of 
accounting policy in their gas business saw investors taking a more 
cautious stance. 
 
The negative sentiment towards the company looks to be overdone and 
recent director share purchases have seen a partial share price 
recovery. 
 
The domiciliary care business continues to perform well for Supporta 
but their professional services business has not and needed to be 
rationalised with parts sold.  The company have been in bid talks but 
nothing has yet been concluded.  Deltex Medical still remains 
unprofitable with a slower take up than originally expected of their 
Cardio Q device which measures blood flow and fluid management. 
 
A partial sale and profit was taken in Aero Inventory at GBP5.72 a 
share to raise GBP55,000.  The share price has, since the date of this 
partial sale, fallen back sharply on the expectation that the global 
economic downturn will result in fewer passenger miles being flown 
and a resultant decrease in aircraft servicing needs.  The company 
does have long term contracts and a strong asset backing through the 
stock they hold.  Glisten has seen its shares fall to levels lower 
than that at which it was founded in June 2002, despite the robust 
growth in profits from their strong portfolio of brands.  The fall in 
share price is attributable to some weakness in the confectionary 
division and their high debt levels from the acquisition of Dormen 
Foods in 2007.  This has now rightly forced the company to decide to 
cut the dividend to conserve cash.  This is a fundamentally sound 
business which we expect to recover, so long as profits start to pay 
down debt as we expect. 
 
In August 2007 Clerkenwell Ventures raised GBP26 million to add to the 
GBP4 million which had come from their original admission to AIM in 
2004.  Its strategy had been to acquire restaurant businesses. 
Although a number of potential acquisitions had been considered, no 
businesses had been acquired due to inflated restaurant valuations 
taking time to adjust to the poor outlook for consumer spending.  As 
a result of not investing the money raised, the investment became non 
qualifying for VCT investment.  We have worked with the company and 
they returned to shareholders GBP26.8 million of its near GBP30 million 
of cash.  Ludorum has successfully delivered its first series to the 
BBC of Chuggington, an animated weekday programme of train adventures 
for children. 
 
Whilst some of the falls in share prices have been as a result of a 
general severe mark down in valuations for smaller companies, other 
falls have been due to investor concerns.  This has particularly been 
the case for companies with relatively high debt positions, often 
faced with the prospect of having to renegotiate with a reluctant 
bank looking to rebuild its own lending margins through tougher 
lending terms.  The general poor economic climate has hit consumer 
related companies, with falls in Neutrahealth, Richoux Holdings and 
Media Square, where for the latter any benefits gained from the 
reorganisation plan that is currently being executed are being more 
than offset by lower advertising spend. 
 
Both TripleArc and Xpertise Group were taken over during the year, 
the former at a loss over book cost and the latter a profit.  Falling 
profitability and mounting debt saw a disposal of Payzone which had 
come from a previous merger with our holding in Cardpoint. 
 
Neutrahealth saw its share price fall following a profits warning due 
to pressure on sales of their vitamins, minerals and supplements 
business and increase costs.  Their largest shareholder, Elder 
Pharmaceuticals has stated that it is considering its options 
concerning the company that may or may not involve an offer. 
 
Waterline, the kitchen business, suffered from lower demand, 
undertook a cost cutting exercise, one of which was its decision to 
de list from AIM.  Around a third of all companies on AIM have a 
market capitalisation of less than GBP5m. With profits under pressure 
and one of the primary reasons for being on AIM, that of being able 
to access funding from potential investors, not currently available, 
we are seeing an increasing number of companies considering delisting 
and saving the costs of being quoted. 
 
Outlook 
The economic newsflow continues to be poor with company profits under 
pressure.  For many companies, expansion plans are on hold as they 
look to weather this downturn. Companies with leveraged balance 
sheets are looking to reduce debt through the conservation of cash, 
meaning possible dividend cuts and where possible fund raising from 
investors, although for most smaller companies there is little 
investor appetite. It is though worth noting an increasing number of 
director share purchases in their own companies; a sign, perhaps, 
that a great deal of pessimism is already reflected in the depressed 
valuations for smaller companies and the confirmation of the real 
value they offer for the patient investor.  Smaller companies may 
well remain friendless for some time but when credit markets ease 
trade buyers may well appear should share prices not start to 
pre-empt a turn for the better in the economic cycle. 
 
Rathbone Investment Management Limited 
 
REVIEW OF INVESTMENTS 
 
Portfolio of investments 
The following investments, all of which are incorporated in England 
and Wales (except where otherwise stated), were held at 31 March 
2009: 
 
                                                Valuation 
                                                 movement      % of 
                                 Cost Valuation   in year portfolio 
                                GBP'000     GBP'000     GBP'000  by value 
Top ten venture capital 
investments 
ANS Group plc **                  253       573         5     13.0% 
Connaught plc ***                  30       362      (92)      8.2% 
Cadbury House Limited *           319       319         -      7.2% 
Doubletake Portraits Limited *    250       250         -      5.7% 
Atlantic Global plc               310       248        87      5.6% 
Spice plc                         256       201     (114)      4.6% 
Printing.com plc                  178       155     (106)      3.5% 
Hoole Hall Spa and Leisure        100       100         -      2.3% 
Limited * 
Supporta plc                      250        98      (39)      2.2% 
Deltex Medical Group plc          233        84      (89)      1.9% 
                                2,179     2,390     (348)     54.2% 
Other venture capital 
investments 
Aero Inventory plc                115        70     (229)      1.6% 
Keycom plc **                     408        70      (35)      1.6% 
The Medical House plc             223        58      (21)      1.3% 
AT Communications plc             178        57      (78)      1.3% 
Ludorum plc                        40        50        10      1.1% 
Neutrahealth plc                  173        49      (90)      1.1% 
Huveaux plc                       283        41      (39)      0.9% 
Sanastro Limited *                200        36      (34)      0.8% 
Richoux Holdings plc              250        35      (76)      0.8% 
(prev Gourmet Holdings) 
1st Dental Laboratories plc       200        27      (32)      0.6% 
Aortech International plc         569        25      (43)      0.6% 
Straight plc                       72        25       (4)      0.6% 
Glisten plc                        84        24      (98)      0.5% 
Coffee Republic plc               713        13      (81)      0.3% 
Quadnetics Group plc               34        12       (7)      0.3% 
Clerkenwell Ventures plc           18         8       (3)      0.2% 
Waterline plc *                   243         5      (75)      0.1% 
Media Square plc                  119         3      (33)      0.1% 
Cellcast plc                      194         2       (5)         - 
The Real Good Food Company plc     91         2       (5)         - 
Top Ten Holdings plc              399         1      (19)         - 
Camaxys plc *                     223         -         -         - 
Chariot (UK) plc *                125         -         -         - 
Dipford Group plc +               136         -      (16)         - 
Hill Station plc +                663         -     (398)         - 
Micap plc +                       300         -       (2)         - 
Real Affinity plc +               175         -       (1)         - 
                                6,228       613   (1,414)     13.8% 
Bonds 
First Active 11¿% Bonds           558       245     (324)      5.6% 
(Ireland) 
 
Hedge Funds 
Barclays Bank GAM Diversity       435       372      (44)      8.4% 
Tracker 
Bluecrest Allblue Fund LD ORD     196       228         8      5.2% 
NPV 
Goldman Sachs Dynamic Opp. LD     207       130      (95)      2.9% 
NPV 
                                  838       730     (131)     16.5% 
 
Subtotal                        9,803     3,978   (2,217)     90.1% 
 
Cash at bank and in hand                    435                9.9% 
 
Total investments                         4,413              100.0% 
 
 
 
All investments are quoted on AIM unless otherwise stated: 
*          Unquoted         **        Quoted on the PLUS Market 
***      Full list +          In Administration 
 
 
Investment movements for the year ended 31 March 2009 
 
Additions 
 
                                   Total 
                                   GBP'000 
Follow on investments 
Hill Station plc                     100 
Sundry investments                     1 
                                     101 
Unquoted investments 
Hoole Hall Spa and Leisure Limited   100 
 
Total investments                    201 
 
 
 
Disposals 
 
                                                            Realised 
                                                   Profit/     gain/ 
                                    MV at           (loss) (loss) in 
                           Cost 31/03/08* Proceeds vs cost  the year 
                          GBP'000     GBP'000    GBP'000   GBP'000     GBP'000 
 
Reconstructions/takeovers 
TripleArc plc               247        12       50   (197)        38 
Xpertise Group plc           81        77      140      59        63 
Full disposal 
Payzone plc                 105        83       11    (94)      (72) 
Partial disposals 
Aero Inventory plc           22        57       55      33       (2) 
Clerkenwell Ventures plc    158       106      150     (8)        44 
Connaught plc                 5        76       78      73         2 
Printing.com plc              6         9       10       4         1 
Spice plc                    47        58       71      24        13 
Straight plc                 33        13       23    (10)        10 
Liquidations 
Disperse Group plc          250         -        -   (250)         - 
 
Hedge Funds 
Barclays Bank GAM           228       218      217    (11)       (1) 
Diversity Tracker 
Bluecrest Allblue Fund       26        29       30       4         1 
LD ORD NPV 
Goldman Sachs Dynamic        15        17       16       1       (1) 
Opp. LD NPV 
                          1,223       755      851   (372)        96 
 
* Adjusted for purchases in the year 
 
Statement of Directors' responsibilities 
The Directors are responsible for preparing the Annual Report, the 
Directors Remuneration Report, and the financial statements in 
accordance with applicable law and regulations. 
 
Company law requires the Directors to prepare financial statements 
for each financial year. Under that law the Directors have elected to 
prepare the financial statements in accordance with United Kingdom 
Generally Accepted Accounting Practice (United Kingdom Accounting 
Standards and applicable law). The financial statements are required 
by law to give a true and fair view of the state of affairs of the 
Company and of the profit or loss of the Company for that period.  In 
preparing those financial statements, the Directors are required to: 
 
*           select suitable accounting policies and then apply them 
  consistently; 
*           make judgements and estimates that are reasonable and 
  prudent; 
*           state whether applicable UK Accounting Standards have 
  been followed, subject to any material departures disclosed and 
  explained in the financial statements; and 
*           prepare the financial statements on the going concern 
  basis unless it is inappropriate to presume that the Company will 
  continue in business. 
 
The Directors are also required by the Disclosure and Transparency 
Rules of the Financial Services Authority to include a management 
report containing a fair review of the business and a description of 
the principal risks and uncertainties facing the company. 
 
The Directors are responsible for keeping proper accounting records 
which disclose with reasonable accuracy at any time the financial 
position of the Company and to enable them to ensure that the 
financial statements, and the Directors Remuneration Report, comply 
with the requirements of the Companies Act 1985.  They are also 
responsible for safeguarding the assets of the Company and hence for 
taking reasonable steps for the prevention and detection of fraud and 
other irregularities. 
 
Directors' statement pursuant to the Disclosure and Transparency 
Rules 
Each of the Directors, confirms that, to the best of each person's 
knowledge: 
 
*           the financial statements, prepared in accordance with 
  United Kingdom Generally Accepted Accounting Practice, give a true 
  and fair view of the assets, liabilities, financial position and 
  loss of the Company; and 
 
*           the Directors' Report contained in the Annual Report 
  includes a fair review of the development and performance of the 
  business and the position of the company together with a 
  description of the principal risks and uncertainties that it faces. 
 
Statement as to disclosure of information to Auditors 
The Directors in office at the date of the report have confirmed 
that, as far as they are aware, there is no relevant audit 
information of which the Auditors are unaware. Each of the Directors 
has confirmed that they have taken all the steps that they ought to 
have taken as directors in order to make themselves aware of any 
relevant audit information and to establish that it has been 
communicated to the Auditors. 
 
By order of the Board 
 
 
 
Grant Whitehouse 
Secretary 
Kings Scholars House 
230 Vauxhall Bridge Road 
London SW1V 1AU 
 
INCOME STATEMENT 
for the year ended 31 March 2009 
 
 
                                 2009                    2008 
                      Revenue Capital   Total Revenue Capital   Total 
                        GBP'000   GBP'000   GBP'000   GBP'000   GBP'000   GBP'000 
 
Income                    146       -     146     218       -     218 
 
Losses on investments       - (2,121) (2,121)       - (1,574) (1,574) 
 
                          146 (2,121) (1,975)     218 (1,574) (1,356) 
 
Investment management    (22)    (68)    (90)    (34)   (100)   (134) 
fees 
 
Other expenses          (155)       -   (155)   (158)     (6)   (164) 
 
Return on ordinary 
activities               (31) (2,189) (2,220)      26 (1,680) (1,654) 
 before tax 
 
Tax on ordinary             -       -       -       -       -       - 
activities 
 
Return attributable 
to equity                (31) (2,189) (2,220)      26 (1,680) (1,654) 
 shareholders 
 
Basic and diluted 
return per             (0.2p) (16.5p) (16.7p)    0.2p (12.0p) (11.8p) 
share 
 
 
The revenue and capital movements in the year relate to continuing 
operations.  The total column within the Income Statement represents 
the profit and loss account of the Company. 
 
A Statement of Total Recognised Gains and Losses has not been 
prepared as all gains and losses are recognised within the Income 
Statement as noted above. 
 
RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS 
for the year ended 31 March 2009 
 
 
                                          2009      2008 
                                         GBP'000     GBP'000 
 
Opening shareholders' funds              6,832     9,108 
Purchase of own shares                   (199)     (346) 
Total recognised losses for the year   (2,220)   (1,654) 
Distributions paid                           -     (276) 
 
Closing shareholders' funds              4,413     6,832 
 
 
 
BALANCE SHEET 
at 31 March 2009 
 
 
                                             2009              2008 
 
                                  GBP'000     GBP'000   GBP'000     GBP'000 
 
Fixed assets 
Investments                                 3,978             6,749 
 
Current assets 
Debtors                              53               191 
Cash at bank and in hand            435                42 
                                    488               233 
 
Creditors: amounts falling due 
within one year                    (53)             (150) 
 
Net current assets                            435                83 
 
Net assets                                  4,413             6,832 
 
 
Capital and reserves 
Called up share capital                     3,285             3,396 
Capital redemption reserve                  1,126             1,015 
Share premium                                 348               348 
Investment holding losses                 (5,825)           (4,076) 
Capital reserve - realised                  5,454             6,093 
Revenue reserve                                25                56 
 
Equity shareholders' funds                  4,413             6,832 
 
Basic and diluted net asset value           33.6p             50.3p 
per share 
 
 
CASH FLOW STATEMENT 
for the year ended 31 March 2009 
 
 
                                       Year ended          Year ended 
                                    31 March 2009       31 March 2008 
                                    GBP'000   GBP'000   GBP'000     GBP'000 
 
Net cash outflow from operating             (129)                (88) 
activities 
 
Capital expenditure 
Purchase of investments             (201)           (2,438) 
Sale of investments                 1,005             2,044 
 
Net cash inflow/(outflow)                     804               (394) 
from capital expenditure 
 
Equity distributions paid                       -               (276) 
 
Net cash inflow/(outflow) before              675               (758) 
financing 
 
Financing 
Purchase of own shares              (199)             (436) 
Net cash outflow from financing             (199)               (436) 
 
Increase/ (decrease) in cash in the           476             (1,194) 
year 
 
 
 
 
 
 
NOTES TO THE ACCOUNTS 
for the year ended 31 March 2009 
 
1. Accounting policies 
 
Basis of accounting 
The Company has prepared its financial statements under UK Generally 
Accepted Accounting Practice ("UK GAAP") and in accordance with the 
Statement of Recommended Practice "Financial Statements of Investment 
Trust Companies and Venture Capital Trusts" January 2009 ("SORP"). 
 
The financial statements are prepared under the historical cost 
convention except for the revaluation of certain financial 
instruments. 
 
The Company implements new Financial Reporting Standards ("FRS") 
issued by the Accounting Standards Board when required.  No new 
standards were issued for implementation for the year under review. 
The Association of Investment Companies issued a new SORP in January 
2009 which has been adopted for these financial statements.  No 
comparative restatements have been required as a result of the 
implementation of the new SORP. 
 
Presentation of Income Statement 
In order to better reflect the activities of a Venture Capital Trust 
and in accordance with guidance issued by the Association of 
Investment Companies ("AIC"), supplementary information which 
analyses the income statement between items of a revenue and capital 
nature has been presented alongside the Income Statement. The net 
revenue is the measure the Directors believe appropriate in assessing 
the Company's compliance with certain requirements set out in Part 6 
of the Income Tax Act 2007. 
 
Investments 
Venture capital investments are designated as "fair value through 
profit or loss" assets due to investments being managed and 
performance evaluated on a fair value basis.   A financial asset is 
designated within this category if it is both acquired and managed on 
a fair value basis, with a view to selling after a period of time, in 
accordance with the Company's documented investment policy.  The fair 
value of an investment upon acquisition is deemed to be cost. 
Thereafter investments are measured at fair value in accordance with 
the International Private Equity and Venture Capital Valuation 
Guidelines "IPEV" together with FRS26. 
 
Listed fixed income investments, hedge funds, investments quoted on 
AIM and those traded on the PLUS Market are measured using bid prices 
in accordance with the IPEV. 
 
In respect of unquoted instruments, fair value is established by 
using the IPEV. The valuation methodologies for unquoted entities 
used by the IPEV to ascertain the fair value of an investment are as 
follows: 
 
*           Price of recent investment; 
*           Earnings multiple; 
*           Net assets; 
*           Discounted cash flows or earnings (of underlying 
  business); 
*           Discounted cash flows (from the investment); and 
*           Industry valuation benchmarks. 
 
The methodology applied takes account of the nature, facts and 
circumstances of the individual investment and uses reasonable data, 
market inputs, assumptions, estimates in order to ascertain fair 
value. 
 
Where an investee company has gone into receivership or liquidation 
the loss on the investment, although not physically disposed of, is 
treated as being realised. 
 
Gains and losses arising from changes in fair value are included in 
the income statement as a capital item and transaction costs on 
acquisition or disposal of the investment expensed. 
 
It is not the Company's policy to exercise either significant or 
controlling influence over investee companies.  Therefore the results 
of these companies are not incorporated into the revenue account 
except to the extent of any income accrued. 
 
Income 
Dividend income from investments is recognised when the shareholder's 
right to receive payment has been established; normally the ex 
dividend date. 
 
Interest income is accrued on a time apportionment basis, by 
reference to the principal sum outstanding and at the effective 
interest rate applicable and only where there is reasonable certainty 
of collection. 
 
Expenses 
All expenses are accounted for on an accruals basis. In respect of 
the analysis between revenue and capital items presented within the 
income statement, all expenses have been presented as revenue items 
except as follows: 
 
Expenses which are incidental to the acquisition of an investment are 
deducted from the Capital Account. 
 
Expenses which are incidental to the disposal of an investment are 
deducted from the disposal proceeds of the investment. 
 
Expenses are split and presented partly as capital items where a 
connection with the maintenance or enhancement of the value of the 
investments held can be demonstrated and accordingly the investment 
management fee and finance costs have been allocated 25% to revenue 
and 75% to capital, in order to reflect the Directors' expected 
long-term view of the nature of the investment returns of the 
Company. 
 
Taxation 
The tax effects on different items in the Income Statement are 
allocated between capital and revenue on the same basis as the 
particular item to which they relate using the Company's effective 
rate of tax for the accounting period. 
 
Due to the Company's status as a Venture Capital Trust and the 
continued intention to meet the conditions required to comply with 
Part 6 of the Income Tax Act 2007, no provision for taxation is 
required in respect of any realised or unrealised appreciation of the 
Company's investments which arises. 
 
Deferred taxation is provided in full on timing differences that 
result in an obligation at the balance sheet date to pay more tax, or 
a right to pay less tax, at a future date, at rates expected to apply 
when they crystallise based on current tax rates and law. Timing 
differences arise from the inclusion of items of income and 
expenditure in taxation computations in periods different from those 
in which they are included in the accounts and is recognised on a 
non-discounted basis. 
 
Other debtors and other creditors 
Other debtors (including accrued income) and other creditors are 
included within the accounts at amortised cost, equivalent to the 
fair value of the expected balance receivable/payable by the Company. 
 
2. Return per share 
 
Revenue return per Ordinary Share is based on the net revenue loss 
after taxation of GBP31,000 (2008: return GBP26,000) in respect of 
13,300,205 Ordinary Shares (2008: 14,003,193), being the weighted 
average number of ordinary shares in issue during the year. 
 
Capital return per Ordinary Share is based on the net capital loss 
for the financial year of GBP2,189,000 (2008: GBP1,680,000) in respect of 
13,300,205 Ordinary Shares (2008: 14,003,193), being the weighted 
average number of ordinary shares in issue during the year. 
 
As the Company has not issued any convertible securities or share 
options, there is no dilutive effect on return per ordinary share. 
The return per share disclosed therefore represents both basic and 
diluted return per ordinary share. 
 
3. Net Asset Value per Ordinary Share 
 
                                     2009                      2008 
                Net asset value Net asset Net asset value Net asset 
                      per share     value       per share     value 
                          pence     GBP'000           pence     GBP'000 
 
Ordinary shares            33.6     4,413            50.3     6,832 
 
 
Net Asset Value per Ordinary Share is based on net assets at the 
year-end, and on 13,140,436 Ordinary Shares (2008: 13,586,073), being 
the number of Ordinary Shares in issue at the year-end. 
 
As the Company has not issued any convertible securities or share 
options, there is no dilutive effect on Net Asset Value per Ordinary 
Share.  The Net Asset Value per share disclosed therefore represents 
both basic and diluted Net Asset Value per Ordinary Share. 
 
4. Principal financial risks 
The principal financial risks faced by the Company, include interest 
rate, liquidity, investment and marketability risks. 
 
In addition to these risks, the Company, as a fully listed Company on 
the London Stock Exchange and as a Venture Capital Trust, operates in 
a complex regulatory environment and therefore faces a number of 
related risks.  A breach of the VCT Regulations could result in the 
loss of VCT status and consequent loss of tax reliefs currently 
available to Shareholders and the Company being subject to capital 
gains tax.  Serious breaches of other regulations, such as the UKLA 
Listing Rules and the Companies Act 1985, could lead to suspension 
from the Stock Exchange and damage to the Company's reputation. 
 
The Board reviews and agrees policies for managing each of these 
risks. They receive quarterly reports from the Managers which monitor 
the compliance of these risks, and place reliance on the Managers to 
give updates in the intervening periods. These policies have remained 
unchanged since the beginning of the financial period. 
 
The principal financial risks are outlined further as follows: 
 
Market risks 
The key market risks to which the Company is exposed are interest 
rate risk and market price risk. 
 
Interest rate risk 
The Company receives interest on cash deposits at a rate agreed with 
its banker, while investments in loan stock and fixed interest 
investments predominately attract interest at fixed rates.  As the 
Company must comply with the VCT regulations, increases in interest 
rates could lead to a potential breach of these regulations as the 
proportion of the Company's income from sources other than shares and 
securities could exceed the required level.  The Company therefore 
monitors the level of income received from fixed, floating and non 
interest rate assets to ensure that the regulations are not breached. 
 
The Company has reviewed the financial impact of the interest rate 
risk, with 0.5% change in base rate (i.e. reducing base rate to Nil) 
changing income and the return for the year by GBP4,000, equivalent to 
a 5.8% impact on overall income receivable by the Company.  Such a 
change would have an immaterial impact on Net Asset Value. 
 
Market price risk 
Market price risk arises from uncertainty about the future prices of 
financial instruments held in accordance with the Company's 
investment objectives.  It represents the potential loss that the 
Company might suffer through holding market positions in the face of 
market movements. At 31 March 2009, the net unrealised loss on the 
quoted portfolios (Full list, AIM-quoted, PLUS-quoted and 
Non-qualifying investments) was GBP4.5 million (2008: GBP3.4 million). 
 
The investments the Company holds are, in the main, thinly traded 
and, as such, the prices are more volatile than those of more widely 
traded securities.  In addition, the ability of the Company to 
realise the investments at their carrying value may at times not be 
possible if there are no willing purchasers.  The ability of the 
Company to purchase or sell investments is also constrained by the 
requirements set down for Venture Capital Trusts. 
 
The Board considers each investment purchase to ensure that an 
acquisition will enable the Company to continue to have an 
appropriate spread of market risk and that an appropriate risk reward 
profile is maintained. 
 
It is not the Company's policy to use derivative instruments to 
mitigate market risk, as the Board believes that the effectiveness of 
such instruments does not justify the cost involved. 
 
Credit risk 
Credit risk is the risk that the counterparty to a financial 
instrument is unable to discharge a commitment to the Company made 
under that instrument. The carrying values of financial assets best 
represent the maximum credit risk exposure at the balance sheet date. 
 
Credit risk in respect of investments in listed fixed interest 
investments (when held by the Company) is minimised by investing in 
either UK Government Stocks or Banks with an A rating or higher. 
 
Investments in loan stocks comprise a fundamental part of the 
Company's venture capital investments therefore credit risk in 
respect of these investments is managed within the main investment 
management procedures. 
 
Credit risk in respect of interest, dividends and other receivables 
are predominantly covered within the investment management 
procedures. 
 
Liquidity risk 
Liquidity risk is the risk that the Company encounters difficulties 
in meeting obligations associated with its financial liabilities.  As 
the Company only ever has a very low level of creditors and has no 
borrowings, the Board believes that the Company's exposure to 
liquidity risk is minimal. 
 
Announcement based on audited accounts 
The financial information set out in this announcement does not 
constitute the Company's statutory financial statements in accordance 
with section 434 Companies Act 2006 for the year ended 31 March 2009, 
but has been extracted from the statutory financial statements for 
the year ended 31 March 2009, which were approved by the Board of 
Directors on 14 July 2009 and will be delivered to the Registrar of 
Companies following the Company's Annual General Meeting.  The 
Independent Auditor's Report on those financial statements was 
unqualified and did not contain any emphasis of matter nor statements 
under s 498(2) and (3) of the Companies Act 2006. 
 
The statutory accounts for the year ended 31 March 2008 have been 
delivered to the Registrar of Companies and received an Independent 
Auditors report which was unqualified and did not contain any 
emphasis of matter nor statements under S237(2) or (3) of the 
Companies Act 1985. 
 
A copy of the full annual report and financial statements for the 
year ended 31 March 2009 will be printed and posted to shareholders 
shortly. Copies will also be available to the public at the 
registered office of the Company at Kings Scholars House, 230 
Vauxhall Bridge Road, London SW1V 1AU and will be available for 
download from www.downing.co.uk. 
 
=--END OF MESSAGE--- 
 
 
 
 
This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement. 
 

Aim Distribution Trust (LSE:AMD)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Aim Distribution Trust.
Aim Distribution Trust (LSE:AMD)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Aim Distribution Trust.